Pharmaceutical News

RSS

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.

1 Dec 2011

Ranbaxy and Teva announce generic Lipitor agreement

Teva Pharmaceutical Industries Ltd. announced today that pursuant to an agreement between its subsidiary, Teva Pharmaceuticals USA, Inc. and Ranbaxy Laboratories Limited, a portion of the profits from Ranbaxy's sales of Atorvastatin Calcium Tablets during Ranbaxy's 180-day first-to-file exclusivity period, will be paid to Teva.

1 Dec 2011

Oral ingestion of apple polyphenols can prevent colitis in mice

Here's another reason why "an apple a day keeps the doctor away"-according to new research findings published in the Journal of Leukocyte Biology, oral ingestion of apple polyphenols can suppress T cell activation to prevent colitis in mice.

1 Dec 2011

Watson commences shipping of generic LIPITOR

Watson Pharmaceuticals, Inc. today confirmed that Watson Pharmaceuticals, Inc., has launched an authorized generic version of LIPITOR (atorvastatin calcium tablets) as part of an exclusive agreement with Pfizer Inc.

30 Nov 2011

One-time injection after spinal cord injury can limit pain for 8 months

A collaborative research group - led by researchers at Cleveland Clinic - published findings that indicate a one-time injection immediately after spinal cord injury can limit pain for an extended period of time.

30 Nov 2011

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor.

30 Nov 2011

Pfizer backs its highest grosser Lipitor

Pfizer’s Lipitor, a blood cholesterol lowering drug, is a popular one the among general population. However now that a generic competition for the drug has arrived in the market the company has devised discounts and incentives for patients, insurers and companies that process prescriptions that will, at least for the next six months, make the brand name drug about as cheap as or cheaper than the generics.

30 Nov 2011

Dramatic nationwide rise in opioid use for chronic abdominal pain

Across U.S. outpatient clinics between 1997 and 2008, opioid prescriptions for chronic abdominal pain more than doubled, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

30 Nov 2011

Groups push for legislation to encourage Medicaid programs to use generic drugs

A group of pharmacists, generic drug makers and consumer interest organizations are trying to build support for a bill that offers states financial incentives to use generic drugs under Medicaid instead of brand-name drugs, which supporters say will save both states and the federal government money.

30 Nov 2011

Lapatinib could extend survival in women with Her2-positive breast cancer

Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published in the British Journal of Cancer.

30 Nov 2011

Associated Press examines Chinese vaccine makers' entry into international market

"China's vaccine makers are gearing up over the next few years to push exports in a move that should lower costs of lifesaving immunizations for the world's poor and provide major new competition for the big Western pharmaceutical companies," the Associated Press reports in a feature examining the entry of Chinese vaccine makers into the international market.

30 Nov 2011

Legalization of medical marijuana reduces traffic fatalities, alcohol consumption

A groundbreaking new study shows that laws legalizing medical marijuana have resulted in a nearly nine percent drop in traffic deaths and a five percent reduction in beer sales.

30 Nov 2011

DNA gyrase B could rapidly eliminate TB, shorten treatment time

In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections.

30 Nov 2011

FDA approves Watson's ANDA for generic Yaz oral contraceptive

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz oral contraceptive product.

29 Nov 2011

FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for ELIQUIS® (apixaban), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

29 Nov 2011

EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the European Commission (EC) has extended the therapeutic indication for Soliris® (eculizumab) to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS).

29 Nov 2011

UIC recruiting volunteers for study on effectiveness of vitamin D in addition to asthma medication

Researchers at the University of Illinois at Chicago are recruiting volunteers with asthma for a study of whether taking vitamin D can make asthma medication more effective.

29 Nov 2011

Avita Medical announces acquisition of intellectual property from McComb Foundation

Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.

29 Nov 2011

HealthWarehouse.com launches pre-order program for generic Lipitor

HealthWarehouse.com, Inc., a leading VIPPS-accredited, retail mail-order pharmacy, announced today the launch of its pre-order program to enable consumers immediate access to Atorvastatin (Generic Lipitor®) on Dec. 5. HealthWarehouse will offer the medication at up to 50 percent less than the branded versions from retail pharmacies.

29 Nov 2011

Ferrer introduces citicoline oral solution medical food

Ferrer Therapeutics, the U.S. subsidiary of the international pharmaceutical group, Ferrer Grupo, is introducing CerAxon- Oral Solution to the U.S. market, the first and only oral solution medical food containing citicoline, a nutrient naturally produced by the body and found in the brain.

29 Nov 2011

Pharmaceutical News

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Ranbaxy and Teva announce generic Lipitor agreement

Oral ingestion of apple polyphenols can prevent colitis in mice

Watson commences shipping of generic LIPITOR

One-time injection after spinal cord injury can limit pain for 8 months

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

Pfizer backs its highest grosser Lipitor

Dramatic nationwide rise in opioid use for chronic abdominal pain

Groups push for legislation to encourage Medicaid programs to use generic drugs

Lapatinib could extend survival in women with Her2-positive breast cancer

Associated Press examines Chinese vaccine makers' entry into international market

Legalization of medical marijuana reduces traffic fatalities, alcohol consumption

DNA gyrase B could rapidly eliminate TB, shorten treatment time

FDA approves Watson's ANDA for generic Yaz oral contraceptive

FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation

EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome

UIC recruiting volunteers for study on effectiveness of vitamin D in addition to asthma medication

Avita Medical announces acquisition of intellectual property from McComb Foundation

HealthWarehouse.com launches pre-order program for generic Lipitor

Ferrer introduces citicoline oral solution medical food

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News